Suven Pharmaceuticals Ltd Annually Results

Gross Sales

1,197.58

1,051.35

1,340.33

1,320.22

1,009.72

Excise Duty

0

0

0

0

0

Net Sales

1,197.58

1,051.35

1,340.33

1,320.22

1,009.72

Other Operating Income

0

0

0

0

0

Other Income

58.56

61.91

46.36

133.49

67.97

Total Income

1,256.14

1,113.26

1,386.69

1,453.71

1,077.69

Total Expenditure

822.38

645.54

766.17

740.8

569.24

PBIDT

433.76

467.72

620.53

712.92

508.45

Interest

12.35

7.45

12.81

6.23

9.14

PBDT

421.41

460.27

607.72

706.69

499.31

Depreciation

77.49

54.6

47.99

39.1

31.64

Minority Interest Before NP

0

0

0

0

0

Tax

93.34

98.8

144.1

190.4

101.72

Deferred Tax

-14.19

6.59

4.34

23.38

3.62

Reported Profit After Tax

264.77

300.28

411.29

453.8

362.34

Minority Interest After NP

-3.1

0

0

0

0

Net Profit after Minority Interest

267.87

300.28

411.29

453.8

362.34

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

267.87

300.28

411.29

453.8

362.34

EPS (Unit Curr.)

10.52

11.8

16.16

17.83

14.23

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

600

500

200

Equity

25.46

25.46

25.46

25.46

25.46

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

36.21

44.48

46.29

54

50.35

PBDTM(%)

35.18

43.77

45.34

53.52

49.45

PATM(%)

22.1

28.56

30.68

34.37

35.88